NHS in England reports 5% jump in diagnostic imaging tests
This article was originally published in Clinica
The NHS in England has seen a significant increase in imaging and radiodiagnostic testing activity in the 12 months ending 31 March 2010, according to data released yesterday by the Department of Health. Over 37.7 million imaging tests were performed during the period 1 April 2009 to 31 March 2010, an increase of 5% compared with the just under 36 million tests recorded over the same period the previous year. By imaging modality, these included 21.9 million X-rays, 3.7 million computed tomography (CT) scans, 2 million magnetic resonance imaging (MRI) scans, 8.2 million ultrasound scans, 0.6 million tests using radio-isotopes and 1.3 million fluoroscopy examinations.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.